CLOPITAB A 150MG TAB
₹122.20
CLOPITAB A 150MG TAB is a combination tablet containing Clopidogrel 150 mg and Aspirin, used to prevent blood clots and reduce the risk of heart attacks and strokes in patients with cardiovascular diseases through dual antiplatelet action.
Description
CLOPITAB A 150MG TAB combines two antiplatelet agents — Clopidogrel 150 mg and low-dose Aspirin — to provide enhanced protection against thrombotic cardiovascular events. Clopidogrel inhibits the ADP receptor on platelet surfaces, preventing platelet aggregation, while Aspirin blocks the cyclooxygenase (COX) enzyme, reducing the production of thromboxane A2, a promoter of platelet activation.
This dual-action tablet is commonly prescribed for patients with acute coronary syndrome, recent myocardial infarction, ischemic stroke, or those who have undergone coronary stenting procedures. The combination therapy significantly decreases the likelihood of blood clot formation, helping to maintain healthy blood flow.
Patients should take CLOPITAB A 150MG TAB exactly as directed by their healthcare provider and be monitored regularly due to the increased risk of bleeding associated with dual antiplatelet therapy.
Reviews
There are no reviews yet.